Considerations on the clinical development of COVID-19 vaccine from trial design perspectives
COVID-19 has become a global pandemic, and an effective vaccine is needed. During the outbreak, the urgency for developing candidate vaccines has brought distinct challenges to clinical development. An efficacy trial, which measures whether the vaccine reduces the incidence of disease, is ordinarily...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Livre |
Publié: |
Taylor & Francis Group,
2021-03-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Soyez le premier à ajouter un commentaire!